Indian scientists are studying peptidomimetics바카라”stable, synthetic neurotrophin mimics바카라”as a promising treatment for neurodegenerative diseases like Alzheimer바카라™s and Parkinson바카라™s by aiding neuron survival.
A team of Indian scientists is exploring the option of using peptidomimetics or synthetic compounds designed to mimic neurotrophins, as a potential solution to the limitations caused by neurodegenerative diseases (NDs) such as Alzheimer바카라™s and Parkinson바카라™s.
These disorders have posed a major health challenge globally and various studies have been conducted for a treatment course. NDs are marked by the progressive decline of neurons in the central nervous system (CNS) and pose a significant public health challenge, affecting the quality of life of the ageing population
In the study published in the Journal Drug Discovery Today, the scientists from the Institute of Advanced Study in Science and Technology (IASST), an autonomous institute of the Department of Science and Technology (DST), highlighted the potential of peptidomimetics to treat NDs by promoting neuronal growth and survival.
Peptidomimetic drugs 바카라” or synthetic molecules that mimic the structure of natural proteins 바카라” can be repurposed to provide an effective therapeutic strategy to treat NDs by promoting neuronal growth and survival, said the team led by Prof. Ashis K. Mukherjee.
While neurotrophins, proteins crucial for neuronal survival and function, have shown promise as potential treatments, their instability and rapid degradation have hindered their therapeutic application.
IASST scientists have been exploring peptidomimetics, synthetic compounds designed to mimic neurotrophins, as a potential solution to these limitations.
바카라śNeurotrophin peptidomimetics are developed to target specific biological functions and can be valuable tools in drug discovery, especially when natural peptides have limitations like poor oral bioavailability or susceptibility to degradation,바카라ť said the study which is co-authored by IASST researchers Dev Madhubala, Rosy Mahato, Mojibur R. Khan, Asis Bala besides Ashis K. Mukherjee.
바카라śOne of the significant advantages of peptidomimetics is their improved stability and bioavailability compared to endogenous neurotrophins. This means they can be delivered more effectively to the brain and maintain their therapeutic activity for a longer duration,바카라ť the team added.
In addition, peptidomimetics can be designed to be more specific to their target receptors, reducing the risk of side effects.
The research focused on understanding the signaling pathways involved in neuronal growth and survival, the potential pharmacological targets of peptidomimetics, and their therapeutic applications for NDs, said the study.